MIMETAS Alternatives & Competitors
12 companies similar to MIMETAS — Human Tissue Models for Better Therapies
Companies similar to MIMETAS
StemoniX
Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research
CN Bio
Generate human-specific efficacy and safety data with PhysioMimix® microphysiological sys...
Emulate, Inc.
Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of...
Paratus Sciences
Translating evolutionary insights into first-in-class medicines
Rival Readout
Competing with MIMETAS? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Design Pharmaceuticals Inc.
Boundless GPCR drug discovery
Verge Labs
Better drugs, faster. For patients who can’t wait.
InSphero
Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy test...
InvivoSciences® Inc.
Discovery with Human touch
bit.bio
The Cell Coding Company
pixlbio
pixl x bio: from cells to pixels to predictions
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
BellBrook Labs
BellBrook Labs is dedicated to accelerating drug discovery and biological research.
About MIMETAS
MIMETAS, founded in 2013 and headquartered in The Netherlands, operates at the intersection of Biotechnology, Health Care, Information Technology, and VR/AR. The company is renowned for its slogan: Human Tissue Models for Better Therapies. MIMETAS specializes in developing cutting-edge, screenable 3D human disease mode...
CRO Services, Training, Product Development, AI/Automation, Disease Mechanism Understanding, Drug Efficacy and Safety Testing, Target Discovery and Validation, Compound Prioritization and Derisking
Pharmaceutical Companies, Biotech Companies, Academic Researchers, Healthcare Researchers, Regulatory Agencies
Organ-on-a-Chip, 3D Human Disease Models, Predictive Toxicology, Microfluidics, Cell-based Assays, High-throughput Screening, Phenotypic Screening, Microphysiological Systems, Blood-brain Barrier Models, Liver Models, Kidney Models, 3D Cell Culture, Disease Modeling, Pharmaceutical Partnerships, Drug Development
B2B, Platform, DaaS
Service Fee, Product Sales, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around MIMETAS: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at MIMETAS on 8 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.